[HTML][HTML] A systematic review and meta‐analysis of venous thrombosis risk among users of combined oral contraception
MV Dragoman, NK Tepper, R Fu… - … of Gynaecology and …, 2018 - ncbi.nlm.nih.gov
Background Combined oral contraceptives (COC s) containing various progestogens could
be associated with differential risks for venous thromboembolism (VTE). Objective To …
be associated with differential risks for venous thromboembolism (VTE). Objective To …
[HTML][HTML] Estrogen-progestins and progestins for the management of endometriosis
Endometriosis is characterized by frequent recurrences of symptoms and lesions even after
extirpative surgery. Because medical therapies control but do not cure the disease, long …
extirpative surgery. Because medical therapies control but do not cure the disease, long …
[HTML][HTML] Combined hormonal contraception and the risk of venous thromboembolism: a guideline
S Pfeifer, S Butts, D Dumesic, G Fossum, C Gracia… - Fertility and sterility, 2017 - Elsevier
While venous thromboembolism (VTE) is rare in young women of reproductive age,
combined oral contraceptives increase the risk of VTE. In the patient in whom combined …
combined oral contraceptives increase the risk of VTE. In the patient in whom combined …
Birth control pills and thrombotic risks: differences of contraception methods with and without estrogen
H Rott - Hämostaseologie, 2019 - thieme-connect.com
In Germany one-third of the women in fertile age use combined oral contraceptives (COCs),
which consist mostly of ethinylestradiol (EE) and a synthetic progestin. Older COCs with …
which consist mostly of ethinylestradiol (EE) and a synthetic progestin. Older COCs with …
Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis
D Bateson, BE Butcher, C Donovan… - Australian family …, 2016 - search.informit.org
Background: Much scientific, media and patient interest surrounds the risk of venous
thromboembolism (VTE) in women taking combined oral contraceptives (COCs). Objectives …
thromboembolism (VTE) in women taking combined oral contraceptives (COCs). Objectives …
[HTML][HTML] Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patients
K Kostev, J Rex, T Eith, C Heilmaier - GMS German Medical …, 2014 - ncbi.nlm.nih.gov
Background: Nowadays, selective serotonin reuptake inhibitors (SSRIs) are the most
frequently prescribed antidepressants due to their superior clinical efficacy, effectiveness …
frequently prescribed antidepressants due to their superior clinical efficacy, effectiveness …
Sex hormones and venous thromboembolism–from contraception to hormone replacement therapy
J Beyer-Westendorf, R Bauersachs, V Hach-Wunderle… - Vasa, 2018 - econtent.hogrefe.com
The use of sex hormones such as combined oral contraceptives (COC) or hormone
replacement therapy (HRT) increases the risk for venous thromboembolism (VTE) …
replacement therapy (HRT) increases the risk for venous thromboembolism (VTE) …
Метаболические эффекты комбинированной гормональной контрацепции и риск тромботических осложнений
ИВ Кузнецова - Акушерство и гинекология, 2016 - elibrary.ru
Цель исследования. Провести систематизированный обзор литературных данных
относительно влияния на риск венозного и артериального тромбоза комбинированных …
относительно влияния на риск венозного и артериального тромбоза комбинированных …
Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia
EF Girbash, HE Sherif, AM Radwan… - Archives of gynecology …, 2023 - Springer
Objectives To compare the effectiveness of dienogest (DIE) and norethisterone acetate
(NETA) regimens in the treatment of endometrial hyperplasia (EH) without atypia. Methods …
(NETA) regimens in the treatment of endometrial hyperplasia (EH) without atypia. Methods …
Drospirenone‐containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies
N Larivée, S Suissa, F Khosrow‐Khavar… - … Journal of Obstetrics …, 2017 - Wiley Online Library
Background The effects of fourth‐generation drospirenone‐containing combined oral
contraceptives (COC s) on the risk of venous thromboembolism (VTE) are controversial …
contraceptives (COC s) on the risk of venous thromboembolism (VTE) are controversial …